About Dr. Alexandra Sowa

Dr. Alexandra Sowa has spent more than a decade at the forefront of obesity medicine, redefining how we understand metabolic health and the role of GLP-1 medications in sustainable, long-term care.

As a practicing physician, bestselling author, and founder of SoWell, she bridges clinical rigor with compassionate guidance, helping patients, professionals, and the public navigate one of the most rapidly evolving areas in modern medicine.

National Recognition

Leading the Conversation on Obesity Medicine and GLP-1 Therapy

For over ten years, Dr. Sowa has treated obesity as the complex, chronic disease that it is — not a personal failure. Long before GLP-1 medications became household names, she was prescribing them responsibly, studying their long-term effects, and developing structured metabolic frameworks around them.

Today, she is regularly featured by major national media outlets including CNN, CBS News, CNBC, USA Today, and The New York Times, where she provides clarity on emerging research, safety considerations, and the future of metabolic care.

Her work helps translate science into strategy — empowering patients and practitioners alike.

Beyond Prescriptions: A Structured, Physician-Led Approach to Long-Term Metabolic Health

GLP-1 medications can be transformative. But medication alone is rarely enough to sustain meaningful metabolic change.

Through her clinical practice, Dr. Sowa developed the SoWell Method — a personalized, physician-led framework designed to support sustainable results. The program integrates metabolic evaluation, structured nutrition strategy, supplementation, behavioral accountability, and long-term oversight.

In her 10-week virtual clinic, over 90% of patients achieve clinically meaningful weight loss — with a focus on long-term metabolic health, not short-term results.

Medical Oversight

Individualized evaluation and safe GLP-1 integration.

Structured Nutrition Support

Protein optimization, hydration strategy, and metabolic stabilization.

Long-Term Strategy

A plan designed for sustainability — not dependency.

“I’m very proud that my patients never have to suffer through excruciating nausea or constipation from GLP-1s, because I know how to help them avoid these side effects up front. With our GLP-1 Support System, now you can too.”

– Dr. Alexandra Sowa, MD
Dual-board certified Internal Medicine physician and founder of SoWell Health

Diplomate, American Board of Obesity Medicine

Board-certified in Internal Medicine

Medical degree and residency, NYU School of Medicine

Graduated with honors from Johns Hopkins University

Author & National Speaker

Author of the First Comprehensive Guide to GLP-1 Medications

Dr. Sowa is the author of The Ozempic Revolution — the first comprehensive user guide to GLP-1 medications written for patients navigating this new era of metabolic treatment.

In the book, she separates hype from science, explains how these medications truly work, and outlines the structured approach required for long-term success.

Her work has positioned her as a trusted national authority and sought-after keynote speaker on obesity medicine, GLP-1 therapy, and the future of metabolic health.

She speaks regularly to medical organizations, health conferences, and media audiences nationwide.

"This isn't about quick fixes or miracle cures. This is about science finally catching up to what we've long understood: obesity is a disease that requires medical intervention."
– Dr. Alexandra Sowa, MD
“I created SoWell because, in the traditional medical environment, you get a prescription, your doctor says, ‘See you in 3 months’, and there's very little in-between. There's no nutritional support, no behavioral guidance, no education on how the brain work and all the other things that I know are necessary for success on GLP-1s. These drugs are not just magic. This process has a structure and rhyme and reason.”
– Dr. Alexandra Sowa, MD
WHY SHE BUILT SOWELL

She Built the System She Couldn’t Find in Traditional Medicine

In traditional medical environments, treatment often ends with a prescription.

But sustainable metabolic health requires far more.

After years of treating patients struggling not only with weight, but with side effects, misinformation, and lack of long-term guidance, Dr. Sowa recognized a systemic gap in care.

So she built SoWell.

SoWell was founded to provide structured, evidence-based support that complements medical treatment — offering metabolic tools, nutritional guidance, and supplementation strategies developed directly from over a decade of clinical experience.

It is not a replacement for medical care.
It is the missing infrastructure around it.

Where the Conversation Goes Deeper

Outside of the clinic and national media appearances, Dr. Sowa explores the intersection of science, culture, and everyday life.

Through her Substack, she shares thoughtful commentary on health headlines, emerging research, and even the pop-culture moments shaping public health conversations.

Her goal is simple: to make metabolic health approachable, intelligent, and grounded in evidence — wherever the conversation is happening.

Where Medicine Meets Culture

Evidence-based education, media commentary, and real-world context on metabolic health and GLP-1 medications.

Straight Talk on GLP-1s from a Physician Who Prescribes Them

Join Dr. Sowa’s newsletter for evidence-based insights, emerging research, and practical strategies on navigating metabolic health safely and effectively.

No hype. No fear. Just science and strategy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.